Clinical challenges: Myeloma and concomitant type 2 diabetes

Multiple myeloma is a malignant plasma cell disorder that accounts for approximately 10% of all hematological cancers. It is characterized by accumulation of clonal plasma cells, predominantly in the bone marrow. The prevalence of type 2 diabetes is increasing; therefore, it is expected that there w...

Descripción completa

Detalles Bibliográficos
Autores principales: Ali, Mohamed Ahmed, Ahmed, Yasar A, Ibrahim, Abubaker
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3889067/
https://www.ncbi.nlm.nih.gov/pubmed/24455664
http://dx.doi.org/10.4103/2278-330X.119916
_version_ 1782299154613010432
author Ali, Mohamed Ahmed
Ahmed, Yasar A
Ibrahim, Abubaker
author_facet Ali, Mohamed Ahmed
Ahmed, Yasar A
Ibrahim, Abubaker
author_sort Ali, Mohamed Ahmed
collection PubMed
description Multiple myeloma is a malignant plasma cell disorder that accounts for approximately 10% of all hematological cancers. It is characterized by accumulation of clonal plasma cells, predominantly in the bone marrow. The prevalence of type 2 diabetes is increasing; therefore, it is expected that there will be an increase in the diagnosis of multiple myeloma with concomitant diabetes mellitus. The treatment of multiple myeloma and diabetes mellitus is multifaceted. The coexistence of the two conditions in a patient forms a major challenge for physicians.
format Online
Article
Text
id pubmed-3889067
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-38890672014-01-16 Clinical challenges: Myeloma and concomitant type 2 diabetes Ali, Mohamed Ahmed Ahmed, Yasar A Ibrahim, Abubaker South Asian J Cancer Commentary Multiple myeloma is a malignant plasma cell disorder that accounts for approximately 10% of all hematological cancers. It is characterized by accumulation of clonal plasma cells, predominantly in the bone marrow. The prevalence of type 2 diabetes is increasing; therefore, it is expected that there will be an increase in the diagnosis of multiple myeloma with concomitant diabetes mellitus. The treatment of multiple myeloma and diabetes mellitus is multifaceted. The coexistence of the two conditions in a patient forms a major challenge for physicians. Medknow Publications & Media Pvt Ltd 2013 /pmc/articles/PMC3889067/ /pubmed/24455664 http://dx.doi.org/10.4103/2278-330X.119916 Text en Copyright: © South Asian Journal of Cancer http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Commentary
Ali, Mohamed Ahmed
Ahmed, Yasar A
Ibrahim, Abubaker
Clinical challenges: Myeloma and concomitant type 2 diabetes
title Clinical challenges: Myeloma and concomitant type 2 diabetes
title_full Clinical challenges: Myeloma and concomitant type 2 diabetes
title_fullStr Clinical challenges: Myeloma and concomitant type 2 diabetes
title_full_unstemmed Clinical challenges: Myeloma and concomitant type 2 diabetes
title_short Clinical challenges: Myeloma and concomitant type 2 diabetes
title_sort clinical challenges: myeloma and concomitant type 2 diabetes
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3889067/
https://www.ncbi.nlm.nih.gov/pubmed/24455664
http://dx.doi.org/10.4103/2278-330X.119916
work_keys_str_mv AT alimohamedahmed clinicalchallengesmyelomaandconcomitanttype2diabetes
AT ahmedyasara clinicalchallengesmyelomaandconcomitanttype2diabetes
AT ibrahimabubaker clinicalchallengesmyelomaandconcomitanttype2diabetes

Ejemplares similares